title: ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
authors: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
authors: Muneo
authors: M
authors: Ohshiro
authors: Junya
authors: J
authors: Kuroda
authors: Yutaka
authors: Y
authors: Kobayashi
authors: Teruaki
authors: T
authors: Akaogi
authors: Eri
authors: E
authors: Kawata
authors: Nobuhiko
authors: N
authors: Uoshima
authors: Yuri
authors: Y
authors: Kamitsuji
authors: Hiroto
authors: H
authors: Kaneko
authors: Kazuho
authors: K
authors: Shimura
authors: Chihiro
authors: C
authors: Shimazaki
authors: Satoshi
authors: S
authors: Murakami
authors: Mayumi
authors: M
authors: Hatsuse
authors: Akira
authors: A
authors: Okano
authors: Tsutomu
authors: T
authors: Kobayashi
authors: Hitoji
authors: H
authors: Uchiyama
authors: Yosuke
authors: Y
authors: Matsumoto
authors: Shigeo
authors: S
authors: Horiike
authors: Masafumi
authors: M
authors: Taniwaki
mesh_terms: D051722:ADAM Proteins / Q000378:metabolism*; D000071120:ADAMTS13 Protein; D015415:Biomarkers / Q000378:metabolism; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D053208:Kaplan-Meier Estimate; D011379:Prognosis; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use; D018180:Thrombomodulin / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D011994:Recombinant Proteins; D018180:Thrombomodulin; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human